Lung cancer screening in never-smokers: why the evidence supports this choice

Although standard clinical protocols withhold endorsement, Peter Attia examines the evidence supporting lung cancer screening in never-smokers as a rationally justified choice grounded in data. The paradox is striking: while official recommendations remain closed to this population, epidemiological evidence and advances in early detection suggest that certain never-smokers—particularly those with secondary risk factors or family history—may benefit from preventive evaluation. This analysis represents a subtle but significant shift in how personalized preventive medicine approaches risk, challenging the one-size-fits-all dogma. For the longevity-minded reader, the conclusion is unambiguous: the absence of an official guideline does not equal absence of evidence, and the most sophisticated preventive health decisions require looking beyond standard consensus.